Regeneron Pharmaceuticals, Inc.Auburn, United States
Disclosure information not submitted.
Assessing treatment effectiveness when no appropriate comparator exists: low-density lipoprotein cholesterol lowering therapy (LLT) for the prevention of aortic stenosis (AS) as a case example
Monday, August 26, 20242:00 PM – 2:15 PM CEST
Immune-Related Adverse Events of Anti-PD-(L)1 Immunotherapy With and Without Chemotherapy in Patients with Advanced Non-Small Cell Lung Cancer: A Real-World Evidence Study
Tuesday, August 27, 20241:00 PM – 1:15 PM CEST
